NCT00269737View on ClinicalTrials.gov

Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

May 31, 1986

Study Completion Date

February 29, 1988

Conditions
PainCancer
Interventions
DRUG

Fentanyl Transdermal Therapeutic System (TTS)

All Listed Sponsors
lead

Alza Corporation, DE, USA

INDUSTRY

NCT00269737 - Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer | Biotech Hunter | Biotech Hunter